Schistosoma mansoni infection and the occurrence, characteristics, and survival of patients with hepatocellular carcinoma: an observational study over a decade

References

• Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2016. Geneva, World Health Organization; 2018. https://www.who.int/healthinfo/global_burden_disease/estimates/en/ accessed 15 June 2021
   Google Scholar
• Shaker Y, Samy N, Asshour E. Hepatobiliary schistosomiasis. J Clin Transl Hepatol. 2014;2:212–216.
   PubMedGoogle Scholar
• Rudge JW, Webster JP, Lu DB, et al. Identifying host species driving transmission of schistosomiasis japonica, a multihost parasite system, in China. Proc Natl Acad Sci U S A. 2013;110(28):11457–11462.
   PubMed Web of Science ®Google Scholar
• Haggag AA, Rabiee A, Abd Elaziz KM, et al. Mapping of Schistosoma mansoni in the Nile Delta, Egypt: assessment of the prevalence by the circulating cathodic antigen urine assay. Acta Trop. 2017;167:9–17.
   PubMed Web of Science ®Google Scholar
• El Naga IF, Eissa MM, Mossallam SF, et al. Inheritance of Schistosoma mansoni infection incompatibility in Biomphalaria alexandrina snails. Mem Inst Oswaldo Cruz. 2010;105(2):149–154.
   PubMed Web of Science ®Google Scholar
• Toda KS, Kikuchi L, Chagas AL, et al. Hepatocellular Carcinoma Related to Schistosoma mansoni Infection: case Series and Literature Review. J Clin Transl Hepatol. 2015;3(4):260–264.
   PubMed Web of Science ®Google Scholar
• El-Ghitany EM, Farghaly AG. Geospatial epidemiology of hepatitis C infection in Egypt 2017 by governorate. Heliyon. 2019;5(8):e02249.
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Egypt, El-Zanaty and Associates, Egypt, ICF International. Egypt Health Issues Survey. Cairo, Egypt and Rockville MD . USA: Ministry of Health and ICF International; 2015.
   Google Scholar
• El-Akel W, El-Sayed MH, El Kassas M, et al. National treatment programme of hepatitis C in Egypt: hepatitis C virus model of care. J Viral Hepat. 2017;24(4):262–267.
   PubMed Web of Science ®Google Scholar
• Kandeel A, Genedy M, El-Refai S, et al. The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment. Liver Int. 2017;37(1):45–53.
   PubMed Web of Science ®Google Scholar
• Shousha HI, Said M, ElAkel W, et al. Assessment of facility performance during mass treatment of chronic hepatitis C in Egypt: enablers and obstacles. J Infect Public Health. 2020;13(9):1322–1329.
   PubMed Web of Science ®Google Scholar
• Elsammak MY, Amin GM, Khalil GM, et al. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis. Clin Biochem. 2006;39(6):623–629.
   PubMed Web of Science ®Google Scholar
• Van Tong H, Brindley PJ, Meyer CG, et al. Parasite Infection, Carcinogenesis and Human Malignancy. EBioMedicine. 2017;15:12–23.
   PubMed Web of Science ®Google Scholar
• Roderfeld M, Padem S, Lichtenberger J, et al. Schistosoma mansoni Egg-Secreted Antigens Activate Hepatocellular Carcinoma-Associated Transcription Factors c-Jun and STAT3 in Hamster and Human Hepatocytes. Hepatology. 2020;72(2):626–641.
   PubMed Web of Science ®Google Scholar
• El-Tonsy MM, Hussein HM, Tel-S H, et al. Schistosoma mansoni infection: is it a risk factor for development of hepatocellular carcinoma? Acta Trop. 2013;128(3):542–547.
   PubMed Web of Science ®Google Scholar
• Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380.
   PubMed Web of Science ®Google Scholar
• De Lédinghen V, Vergniol J. Transient elastography (FibroScan). Gastrœntérol Clin Bio. 2008;32(6):58–67.
   PubMedGoogle Scholar
• Hsu CY, Lee YH, Hsia CY, et al. Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system. Hepatology. 2013;57(1):112–119.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. Electronic address: [email protected]; European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma [published correction appears in J Hepatol. 2019; 70(4):817]. J Hepatol. 2018;69(1): 182–236.
   PubMed Web of Science ®Google Scholar
• Lencioni R, JM L. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30(1):52–60.
   PubMed Web of Science ®Google Scholar
• Verslype C, Rosmorduc O, Rougier P. ESMO Guidelines Working Group. Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 7):vii41–8.
   PubMed Web of Science ®Google Scholar
• Chan YH. Biostatistics102: quantitative Data – parametric & Non-parametric Tests. Singapore Med J. 2003;44(8):391–396.
   PubMedGoogle Scholar
• Chan YH. Biostatistics 203: survival analysis. Singapore Med J. 2004;45(6):249.
   PubMedGoogle Scholar
• Gundamaraju R. Novel antipathy for schistosomiasis-the most lethal ailment of the tropical region. Asian Pac J Trop Biomed. 2014;4(Suppl1):S43–S45.
   PubMedGoogle Scholar
• Boissier J, Grech-Angelini S, Webster BL, et al. Outbreak of urogenital schistosomiasis in Corsica (France): an epidemiological case study. Lancet Infect Dis. 2016;16(8):971–979.
   PubMed Web of Science ®Google Scholar
• EL-Ghitany EM. Hepatitis C virus infection in Egypt: current situation and future perspective. Journal of high institute of public health. 2019;49(1):1–9.
   Google Scholar
• Filgueira NA, Saraiva CMA, Jucá NT, et al. Schistosomal liver fibrosis and hepatocellular carcinoma - case series of patients submitted to liver transplantation. Braz J Infect Dis. 2018;22(4):352–354.
   PubMed Web of Science ®Google Scholar
• El-Tonsy MM, Hussein HM, Tel-S H, et al. Human Schistosomiasis mansoni associated with hepatocellular carcinoma in Egypt: current perspective. J Parasit Dis. 2016;40(3):976–980.
   PubMedGoogle Scholar
• Ar E-Z, Hm B, Em B, et al. Hepatocellular carcinoma in Egypt: a single center study over a decade. World J Gastroenterol. 2005;11(33):5193–5198.
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman M, El-Sayed M, El Raziky M, et al. Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response. World J Gastroenterol. 2013;19(17):2691–2696.
   PubMed Web of Science ®Google Scholar
• Gasim GI, Bella A, Adam I. Schistosomiasis, hepatitis B and hepatitis C co-infection. Virol J. 2015;12(1):19.
   PubMedGoogle Scholar
• Salama II, Sami SM, Said ZN, et al. Effectiveness of hepatitis B virus vaccination program in Egypt: multicenter national project. World J Hepatol. 2015;7(22):2418–2426.
   PubMed Web of Science ®Google Scholar
• Abdel Gawad SS, Abu-Sarea EY, Saleh L. Epidemiological determinants correlating hepatitis C and Schistosomiasis mansoni in one of Upper Egypt governorates. Beni-Suef Univ J Basic Appl Sci. 2018;7(2):171–177.
   Google Scholar
• Ahmed L, Salama H, Ahmed R, et al. Evaluation of Fibrosis Sero-Markers versus Liver Biopsy in Egyptian Patients with Hepatitis C and/or NASH and/or Schistosomiasis. Parasitol United J. 2009;2:67–76.
   Google Scholar
• Esmat G, Elsharkawy A, El Akel W, et al. Fibroscan of chronic HCV patients coinfected with schistosomiasis. Arab J Gastroenterol. 2013;14(3):109–112.
   PubMed Web of Science ®Google Scholar
• Toshikuni N. Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis. Gut Liver. 2017;11(3):335–348.
   PubMed Web of Science ®Google Scholar
• Bahgat MM, El-Far MA, Mesalam AA, et al. Schistosoma mansoni soluble egg antigens enhance HCV replication in mammalian cells. J Infect Dev Ctries. 2010;4(4):226–234.
   PubMed Web of Science ®Google Scholar
• Sabry Ael H, El-Aal AA, Mahmoud NS, et al. An initial indication of predisposing risk of schistosoma mansoni infection for hepatocellular carcinoma. J Egypt Soc Parasitol. 2015;45(2):233–240.
   PubMedGoogle Scholar
• Olveda DU, Olveda RM, McManus DP, et al. The chronic enteropathogenic disease schistosomiasis. Int J Infect Dis. 2014;28:193–203.
   PubMed Web of Science ®Google Scholar